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Numerous linkage studies have indicated chromosome
18q21–22 as a locus of importance for blood pressure
regulation. This locus harbors the neural precursor cell
expressed developmentally downregulated 4-like (NEDD4L)
gene, which is instrumental for the regulation of the
amiloride-sensitive epithelial sodium channel (ENaC). In a
linkage study of 16 markers (including two single nucleotide
polymorphism markers located within the NEDD4L gene) on
chromosome 18 between 70–104 cM and ambulatory blood
pressure (ABP), in 118 families, the strongest evidence of
linkage was found for 24 h and day-time systolic ABP at the
NEDD4L locus (82.25 cM) (P¼ 0.0014). In a large population
sample (n¼ 4001), we subsequently showed that a NEDD4L
gene variant (rs4149601), which by alternative splicing leads
to varying expression of a functionally crucial C2 domain, was
associated with diastolic blood pressure (DBP) (P¼ 0.03) and
DBP progression over time (P¼ 0.04). A genotype
combination of the rs4149601 and an intronic NEDD4L
marker (rs2288774) was associated with systolic blood
pressure (SBP) (P¼ 0.01), DBP (P¼ 0.04), and progression of
both SBP (P¼ 0.03) and DBP (P¼ 0.05) over time. A
quantitative transmission disequilibrium test in the family
material of the rs4149601 supported this NEDD4L variant as
being at least partially causative of the linkage result. In
conclusion, our findings suggest that the chromosome 18
linkage peak at 82.25 cM is explained by genetic NEDD4L
variation affecting cross-sectional and longitudinal blood
pressure, possibly as a consequence of altered NEDD4L
interaction with ENaC.
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Chronically elevated blood pressure is the most prevalent risk
factor for cardiovascular morbidity and mortality world-
wide.1 Blood pressure is a complex phenotype in which
genetic factors explain 30–60% of all variation in the
population.2 However, the genes responsible for this effect
have remained obscure.3 Several candidate gene studies and
genome-wide scans have been performed to find genetic loci
linked to or associated with blood pressure variation and
hypertension. The genome-wide scan approach, as opposed
to candidate gene studies, has the strength to highlight
regions of the genome of importance for blood pressure
regulation independently of available knowledge on blood
pressure physiology. However, a weakness is a high rate of
type 1 and 2 errors, as markers are tested without marker
specific a priori hypotheses. To minimize the risk of these
errors, it is essential to replicate results of genome-wide scans
before moving to positional candidate gene studies. A region
on chromosome 18q21–22 has been implemented in a
number of genome-wide scans on hypertension and blood
pressure4–7 making the locus a suitable candidate for
harboring gene/genes involved in blood pressure regulation.
The first aim of this study was to investigate whether the
chromosome 18q21–22 locus is linked to 24-h ambulatory
blood pressure (ABP) phenotypes in Swedish families in
which we previously found heritabilities, ranging from 29 to
63%, for ABP.8
The 18q21–22 locus harbors an interesting candidate gene:
the neural precursor cell expressed developmentally down-
regulated 4-like (NEDD4L) gene.9 One role of NEDD4L is to
ubiquitinate epithelial sodium channel (ENaC) leading to its
removal from the luminal cell membrane in the renal
collecting ducts.10,11 It might be hypothesized that carrying
loss-of-function variants of the NEDD4L gene leads to
elevated blood pressure via renal hyper-reabsorbtion of
sodium through ENaC and subsequent volume overload.12,13
The NEDD4L protein contains a highly conserved, function-
ally crucial Ca2þ -dependent lipid binding domain (C2
domain).11,14–17 NEDD4L and its paralog NEDD4 lacking
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the C2 domain, downregulate ENaC more potently than
wild-type protein.11,14–17 Recently, a common polymorphism
was identified at the last nucleotide of exon 1 of NEDD4L
(G-A) (rs4149601), leading to alternative splicing18 of the
A-allele with a preferential deletion of the C2 domain.
Hypothetically, carriers of the A-allele could have lower blood
pressure than carriers of the G-variant as the former lack the
C2 domain entirely.18 Furthermore, other variants in the
NEDD4L gene could affect the expression or function of the
protein or be in linkage disequilibrium (LD) with causal
variants. Our second aim was to test if rs4149601 and three
other single nucleotide polymorphisms (SNPs), distributed
evenly along the NEDD4L gene, are associated with blood
pressure variation and blood pressure change over time.
Lastly, we recently showed that genetic variants in the
serum and glucocorticoid-regulated kinase 1 gene, to which
NEDD4L is intimately linked, influence the insulin–blood
pressure correlation.19 Thus, the third aim of this study was
to test if genetic NEDD4L variants confer an increased
strength of the insulin–blood pressure relationship.
RESULTS
Linkage between chromosome 18q21–22 and variation in
ABP phenotypes in the macrovascular and hemodynamic
genetics material
The results of the quantitative trait locus (QTL) analysis of
ABP phenotypes and the region between 70 and 104 cM on
chromosome 18 in the macrovascular and hemodynamic
genetics (MMHG) material are summarized in Figure 1. The
strongest evidence of linkage was at 80.4–82.7 cM, pinpointed
by markers in the NEDD4L gene, for day-time systolic ABP
(logarithm of odds (LOD)¼ 1.95, P¼ 0.0014) and 24-h
systolic ABP (LOD¼ 1.84, P¼ 0.002). Night-time systolic
ABP also showed evidence of linkage at 80.41 cM, although
weaker (LOD¼ 0.77, P¼ 0.03). The linkage at 82.25 cM for
diastolic ABP was of borderline significance during daytime
(LOD¼ 0.59, P¼ 0.05) and 24-h ABP (LOD¼ 0.59,
P¼ 0.05) whereas no evidence of linkage was found for
night-time diastolic ABP. Performing the quantitative trait
locus with only the two markers flanking the NEDD4L gene
and the two SNPs located inside the gene provided the same
linkage result for day-time systolic ABP indicating that much
of the linkage peak in this region can be explained by variance
in the NEDD4L gene (P¼ 0.0014). In the simulations
performed, a higher peak than the one found here for day-
time systolic ABP occurred only seven times out of 1000 by
chance providing an exact P-value for this study of 0.007
indicating that the risk of a type 1 error occurring is quite
small. More distally, a weaker and somewhat less condensed
peak was found with maximal evidence of linkage at 97 cM
for day-time systolic ABP (LOD¼ 1.23, P¼ 0.009), day-time
diastolic ABP (LOD¼ 0.76, P¼ 0.03) and 24-h diastolic ABP
(LOD¼ 0.69, P¼ 0.04) and at 95 cM for 24-h systolic ABP
(LOD¼ 1.11, P¼ 0.01). Quantitative transmission disequili-
brium test analysis showed that the G-allele of the rs4149601
was overtransmitted together with increases in day-time,
night time, and 24-h systolic ABP (Po0.05 for all; 40–79
informative trios) further pinpointing the NEDD4L gene as
the culprit responsible for the linkage to chromosome 18 at
82.25 cM in this study. However, no rs2288774 allele was
significantly overtransmitted to probands with increased
blood pressures (data not shown).
NEDD4L association study results
Genotyping success rate and Hardy–Weinberg equilibrium. In
the total material (n¼ 4830), the genotyping success rate was
89.5% (n¼ 4325) for the rs2288774, 96.8% (n¼ 4675) for
the rs502450, 95.9% (n¼ 4631) for the rs4149601, and 97.2%
(n¼ 4695) for the rs2075403, including patients on anti-
hypertensive medication. The numbers of subjects in the
Results section refer to the exact number of successfully
genotyped subjects. Genotype distributions, in all groups of
subjects studied, were in accordance with Hardy–Weinberg
equilibrium (data not shown).
Variations in the NEDD4L gene and cross-sectional blood
pressure at Malmo¨ diet and cancer material in subjects without
antihypertensive medication. Carriers of the GG-genotype of
the rs4149601 polymorphism had significantly higher
diastolic blood pressure (DBP) compared to carriers of the
AA-genotype (Table 1). The effect of the GG- vs the AA-
genotype on DBP was independent of the effects of age, sex,
and body mass index (BMI) (P¼ 0.02). Systolic blood
pressure (SBP) did not differ between carriers of different
genotypes of rs4149601 (Table 1). Blood pressure in carriers
of different genotypes of the three bi-allelic markers, evenly
distributed over the NEDD4L gene (rs502450 in intron 1,
rs2288774 in intron 6 and rs2075403 in intron 22), is shown
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Figure 1 | Multipoint variance component linkage analysis of
chromosome 18q21–22. The LOD score is displayed on the Y-axis
and the distance in centimorgan over the chromosomes is displayed
on the X-axis. The solid black curve represents the LOD score of the
24-h systolic ambulatory measurement (ABP), the dashed black curve
represents day-time systolic ABP, the shaded black curve represents
night-time systolic ABP, the solid gray curve represents the 24-h
diastolic ABP, the dashed gray curve represents the day-time diastolic
ABP. Night-time diastolic ABP (shaded gray) is tangential with the
X-axis indicating zero evidence of linkage and is therefore not visible.
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in Table 1. Carriers of the CC- or CT-genotype of the
rs2288774 polymorphism had significantly higher SBP
than carriers of the TT-genotype (Table 1). The effect
of the C-allele on SBP was independent of the effects
of age, sex, and BMI (P¼ 0.006). There were no significant
differences in blood pressure between carriers of different
genotypes of the rs502450 and rs2075403 (Table 1).
Owing to the fact that the rs4149601 and rs2288774 SNPs
belong to different LD blocks we found it relevant to study
the two SNPs together as an additive effect cannot be
excluded and LD with other non-studied SNPs could be
reflected in such an analysis. Hence, we constructed a
genotype combination consisting of subjects simultaneously
carrying the rs2288774 CC/CT-genotype and the rs4149601
GG-genotype (NEDD4L risk-genotype combination). Car-
riers of the NEDD4L risk-genotype combination had
significantly higher blood pressures (Table 1) compared to
subjects with any other genotype combination (non-carriers)
independent of age, sex, and BMI for both SBP (P¼ 0.02)
and DBP (P¼ 0.002). In an exploratory analysis of hyper-
tension vs normotension at Malmo¨ diet and cancer material
(MDC) (n¼ 4293), the frequency of the NEDD4L risk-
genotype combination did not differ between patients with
hypertension (30.6%) compared to those with normotension
(30.2%) (P¼ 0.80).
Variations in the NEDD4L gene and longitudinal blood
pressure in subjects without antihypertensive medication. The
change in DBP from ‘Malmo¨ Preventive Project’ (MPP) to
MDC in subjects without antihypertensive medication was
greater in carriers of the GG- vs AA-genotype of the
rs4149601 polymorphism (Table 2), whereas these variables
did not differ significantly when subjects were grouped by
rs2288774- (Table 4), rs502450- or rs2075403 genotypes
(data not shown). The effect of the rs4149601 GG- vs AA-
genotype on change in DBP from MPP to MDC was
independent of age, sex, BMI at MPP, BMI at MDC, change
in BMI from MPP to MDC, follow-up time, and baseline
blood pressure at MPP (P¼ 0.01). Both SBP and DBP
increased more rapidly from MPP to MDC in carriers of the
NEDD4L risk-genotype combination compared to non-
carriers (Table 2). The effect on change in systolic
(P¼ 0.004) and diastolic (P¼ 0.002) blood pressure over
time was independent of age, sex, BMI at MPP, BMI at MDC,
change in BMI from MPP to MDC, follow-up time, and
blood pressure at MPP.
NEDD4L risk-genotype combination and strength of the
insulin–blood pressure correlation in subjects without antihyper-
tensive medication. In untreated subjects at MDC, the
strength of the correlation between fasting insulin concen-
tration and blood pressure did not differ significantly
between carriers and non-carriers of the NEDD4L risk-
genotype combination, neither for insulin–SBP (P¼ 0.31)
nor for insulin–DBP (P¼ 0.33). Excluding diabetics from the
analysis did not alter the results.
DISCUSSION
In this study, we found linkage to 24-h systolic ABP, day-time
systolic ABP, and night-time systolic ABP at 82.25 cM in
Swedish families, a region that has previously been shown to
be linked to multiple blood pressure phenotypes.4–7 This
locus harbors the NEDD4L gene, a key regulator of the ENaC.
One SNP marker, rs4149601, located in the first exon of the
NEDD4L gene was found to be associated with ABP variation
in our family material. The same marker has recently been
found to be associated with blood pressure phenotypes and
hypertension.20,21 However, in one of these studies, the G
allele of the rs4149601 variant was associated with hyperten-
sion.20 We were therefore encouraged to test whether this
SNP and three other SNPs distributed evenly along the
NEDD4L gene is associated with blood pressure variation in a
large population sample. We found that the rs4149601 GG-
genotype is associated with increases in DBP and faster
progression of DBP over time. Additionally, we found that
the C-allele of the rs2288774 was associated with higher SBP.
Finally, concomitant carrier-ship of these at-risk genotypes
increased SBP and DBP as well as progression of SBP and
DBP over time.
Table 1 | Blood pressure phenotypes in the MMHG (n=260)
Blood pressure
(mm Hg) OBP 24-h ABP
Day-time
ABP
Night-
time ABP
SBP 119714 123710*** 127710*** 115711***
DBP 73710 7677*** 8078*** 6878***
MBP 89710 9278*** 9678*** 8378***
PP 4679 4776** 4776** 4776**
ABP, ambulatory blood pressure; DBP, diastolic blood pressure; MBP, mean blood
pressure; MMHG, macrovascular and hemodynamic genetics; OBP, office blood
pressure; PP, pulse pressure; SBP, systolic blood pressure.
Blood pressure phenotypes in MMHG delineated as mean7s.d.
***Po0.001 in comparison with OBP; **Po0.01 in comparison with OBP.
Table 2 | Clinical characteristics of blood pressure and
hypertensive groups
MPP without
AHT and MPP to
MDC (n=2171)
MDC
without AHT
(n=4001)
MDC
with AHT
(n=829)
Age (years) 47.275.7 57.476.0 59.575.5
BMI (kg/m2) 24.273.2 25.773.7 27.774.3
Sex (% male) 54 41 45
SBP (mm Hg) 123713.2 140718.1 152719.2
DBP (mm Hg) 81.978.4 86.179.0 92.179.6
P-insulin (mIU/l)* 8.8 (5.0–9.0) 7.0 (5.0–9.0) 9.0 (6.0–12.0)
DM (% yes) 0.5 6.3 19.1
Follow-up time (years)* 12.5 (7.79–14.51) — —
DSBP (mm Hg/year)* 1.56 (0.69–2.63) — —
DDBP (mm Hg/year)* 0.37 (0.00–0.95) — —
DSBP (%/year)* 1.27 (0.54–2.24) — —
DDBP (%/year)* 0.78 (0.00–1.21) — —
AHT, antihypertensive treatment; DBP, diastolic blood pressure; DDBP, change in
DBP from MPP to MDC; DM, diabetes mellitus; IQR, interquartile range; MDC, Malmo¨
Diet and Cancer; MPP, Malmo¨ Preventive Project; SBP, systolic blood pressure; DSBP,
change in SBP from MPP to MDC.
All variables except frequency variables are shown as mean7s.d. or where indicated
with * as median and interquartile range. Follow-up time and D-values refers to MPP
to MDC.
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Within the region of linkage to systolic ABP in the
MMHG material (Figure 1) there are a multitude of genes.
However, based on position and available knowledge on
function, the NEDD4L gene is an excellent candidate and
quantitative transmission disequilibrium test analysis of the
rs4149601 suggested that variance within this gene is likely to
be the main contributor to this linkage peak. NEDD4L
functions as a remover of ENaC through interaction between
NEDD4L WW domains and the ENaC PY motif.22 Liddle’s
syndrome, in which the PY motif is deleted or altered, is a
direct consequence of excess ENaC-mediated sodium reab-
sorbtion in the renal tubules, indicating the importance of
NEDD4L-ENaC interaction in human blood pressure
regulation and that common variants in these genes could
affect population blood pressure. ENaC itself does not harbor
any common functional variants.23,24 However, a common
G-A variant at the last nucleotide in exon 1 (rs4149601) of
the NEDD4L gene was recently reported.18 The A-variant
activates an alternative splice site generating a transcript
without exons 2–6 rendering the protein deficient of the C2
domain.18 As deletion of the C2 domain in the NEDD4L gene
and in the closely related paralog NEDD4 was shown to
increase downregulation of ENaC in non-human cell
systems,11,15 it can be speculated that carriers of the
rs4149601 A-allele have enhanced NEDD4L-induced down-
regulation of ENaC, decreased renal sodium reabsorption,
and lower blood pressure. We show that carriers of the AA-
genotype when compared to carriers of the GG-genotype
have lower DBP. They also display a slower progression of
DBP during the clinically highly relevant age span of 47–57
years, during which the incidence of hypertension increases
dramatically in most populations.25 Three additional SNPs in
the NEDD4L gene were studied. These SNPs were selected in
an attempt to increase the chance to detect further genetic
blood pressure effects of NEDD4L variants and all four SNPs
studied belonged to different LD block and could theoreti-
cally act as tag-SNPs predicting a haplotype carrying a
functional variant. We found that carriers of the C-allele of
the rs2288774 polymorphism had significantly higher SBP,
suggesting that this polymorphism either is in LD with a
functional variant or that is functional itself. Subjects
carrying the NEDD4L risk-genotype combination had
higher SBP, DBP, and increased progression rate of both
SBP and DBP.
In concordance with our findings, the effect of individual
SNPs in a highly multifactorial phenotype like blood pressure
is expected to be small, thus inferring little clinical relevance
at the individual level. However, together with other genetic
variants, clinically relevant risk-predictive genotype batteries
may be created in the future. Detecting these small individual
genetic effects requires large materials with high power. It can
be speculated that the rs4149601, rs2288774 polymorphisms,
and the NEDD4L risk-genotype combination have more
pronounced effects on subphenotypes of blood pressure
dependent on renal sodium reabsorption, such as salt
sensitivity. It should also be emphasized that subjects with
diagnosed hypertension were excluded from the blood
pressure analysis due to unreliable blood pressure values.
Such exclusion could only lessen the power to detect a genetic
effect and lead to underestimation of the effect of the studied
SNPs, as hypertensives would theoretically have the highest
frequency of risk genotypes.
It should be kept in mind that subjects carrying the
A-allele of the rs4149601 polymorphism lack the C2
domain18 in a facultative fashion. Thus, in this study it is
unknown to what extent the C2 domain is expressed in
individual subjects carrying the A-allele.
The participation rate (48.4%) of the MDC investigation
implies a non-optimal representation of the inhabitants of
the city of Malmo¨. Individuals participating in the investi-
gation were healthier, came from higher social standards and
had a lower load of hazardous environmental factors than the
average citizen.26 Diminuating environmental factors could
probably increase the power to detect phenotype-influencing
genetic anomalies in studies of complex diseases, thus
increasing the power of this study to detect an effect of
genetic NEDD4L variance.
The MMHG family material used in the linkage study
included a much smaller number of subjects. Despite this we
were able to show significant evidence of linkage to systolic
ABP at 82.25 cM and borderline significant evidence of linkage
to daytime and 24-h diastolic ABP. This may be explained, in
part, by the fact that ABP is a more exact measurement of
‘true’ blood pressure and is more heritable than office blood
pressure,8 thus giving studies of ABP-phenotyped materials
greater power to detect genetic effects than similar office blood
pressure studies. However, it is also important to stress that
linkage reflects co-inheritance between relatively large geno-
mic regions and blood pressure levels within families. Thus, it
is possible that our linkage result, which was stronger than
expected when considering the small effects of rs4149601 and
rs2288774 on population blood pressure (Table 2), reflects
familial co-inheritance of many genetic variants of importance
for blood pressure in the NEDD4L gene and in other adjacent
genes. Considering that 490% of the probands had first-
degree relatives with diagnosed hypertension it is also
plausible that the genetic load of hypertension causing genes
is greater in the MMHG than the general population. Based
on the data in the present study it is impossible to estimate
how much of the linkage at 82.25 cM is due to rs4149601 and
rs2288774 but the quantitative transmission disequilibrium
test implies that at least the rs4149601 variant contribute
substantially to the linkage result.
The notion that the direct relationship between circulating
fasting insulin and blood pressure27 would be stronger in
carriers of NEDD4L variants associated with increased blood
pressure was not supported by the present study. Considering
the small effects on blood pressure of the studied NEDD4L
variants it cannot be excluded that NEDD4L, as one factor in the
insulin, serum and glucocorticoid-regulated kinase 1, NEDD4L,
ENaC system, could harbor SNPs of physiological importance in
mediating part of the insulin–blood pressure relationship.
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Conclusion
The genetic NEDD4L variants are common in the population
and, as expected in a complex trait, their effect on blood
pressure and blood pressure progression rate is small, thus
representing one important factor in the understanding of
the polygenic background of population blood pressure
regulation. Together with other common genetic variants
affecting blood pressure, they may be helpful in predicting
high blood pressure in normotensive individuals. Taken into
account the central role of NEDD4L in regulation of ENaC-
mediated renal sodium reabsorption, our results encourage
further studies investigating whether the NEDD4L risk-
genotype combination, on its own or in combination with
other genetic variants of the insulin, serum and glucocorti-
coid-regulated kinase 1, NEDD4L, ENaC blood pressure-
regulating system, have more dramatic effects on subpheno-
types of blood pressure such as salt sensitivity and blood
pressure response to amiloride treatment, thereby identifying
subjects suitable for specific interventions aimed at preven-
tion and treatment of hypertension.
MATERIALS AND METHODS
Subjects
All study participants had given written informed consent. The
Ethics Committee of the Medical Faculty of Lund University
approved the study. The procedures were in accordance with the
institutional guidelines.
Linkage study in ‘Malmo¨ family collection for the study of
MMHG’. From September 2000 until March 2002, 118 Caucasian
families from Malmo¨, Sweden were collected, suitable for heritability
calculations and genetic linkage studies of variation in blood
pressure and related phenotypes (the MMHG material). The
subjects and the phenotyping procedures have previously been
described in detail.8 In brief, probands were ascertained from the
‘Malmo¨ Diet and Cancer Study’ (MDC) and the MPP, two cohort
studies from Malmo¨ in Southern Sweden.28,29 One-hundred-twenty-
one sib-ships free from antihypertensive medication (n¼ 260) were
included in the quantitative trait locus analysis of ABP in the present
study. Sib-ships with one or two parents with diagnosed and
pharmacologically treated primary hypertension were primarily
included in order to enrich the material with genetic hypertension
susceptibility variants. Thus, although being free from a history of
hypertension themselves, 91% of the included subjects hadX1 first-
degree relative with diagnosed primary hypertension. The mean age
of the 260 included subjects was 38.378.6 years, BMI 25.274.0 kg/
m2, heart rate 68.6710 beats per minute and 49% were male. Blood
pressure phenotypes are shown in Table 3. Two-hundred-and-one,
non-phenotyped, additional family members (parents and addi-
tional siblings on antihypertensive medication) were genotyped in
order to increase phase information, that is identity by descent, in
the quantitative trait locus analysis of the 121 sib-ships free from
antihypertensive medication.
Table 3 | Blood pressure at MDC according to the four SNP’s studied and a NEDD4L risk-genotype combination in the
NEDD4L gene
rs4149601 exon 1 G/A polymorphism (n=3836)
GG (n=1646) GA (n=1740) AA (n=450) GA/AA (n=3671) P-value (GG vs AA)
SBP (mm Hg) 140.1718.6 139.8717.8 139.3717.9 139.7718.2 0.45
DBP (mm Hg) 86.478.8 86.179.2 85.378.9 85.979.1 0.02
rs2288774 intron 6 C/T polymorphism (n=3577)
CC (n=807) CT (n=1591) TT (n=1179) CC/CT (n=2398) P-value (CC/CT vs TT)
SBP (mm Hg) 140.0718.5 140.1718.3 138.6717.9 140.1718.4 0.03
DBP (mm Hg) 86.179.0 86.479.1 85.878.9 86.379.0 0.16
rs502450 intron 1 T/C polymorphism (n=3875)
CC (n=3553) CT (n=314) TT (n=8) CC/CT (n=3864) P-value (CC vs CT/TT)
SBP (mm Hg) 139.5718.2 140.3717.8 148.3723.5 139.6718.1 0.36
DBP (mm Hg) 86.179.0 86.879.1 87.078.4 86.879.1 0.15
rs2075403 intron 22 A/G polymorphism (n=3889)
AA (n=248) AG (n=1379) GG (n=2262) AG/GG (n=3641) P-value (AA vs GG)
SBP (mm Hg) 138.6716.8 140.3718.3 139.3718.1 139.7718.3 0.59
DBP (mm Hg) 86.078.8 86.378.9 86.079.0 86.379.0 0.98
rs4149601 GG+rs2288774 CC/CT (NEDD4L risk-genotype combination) vs all other subjects (n=3550)
NEDD4L risk-genotype combination (n=1088) Other genotype carriers (n=2462) P-value
SBP (mm Hg) 140.7718.9 139.1717.8 0.01
DBP (mm Hg) 86.679.0 85.979.0 0.04
DBP, diastolic blood pressure; MDC, Malmo¨ Diet and Cancer; SBP, systolic blood pressure; SNP, single nucleotide polymorphism.
Blood pressures are shown as means7s.d. Analysis performed on individuals free from antihypertensive medication.
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Association studies in the MDC. This study population is a
sample of a cohort study on diet and cancer in Malmo¨, Sweden. Fifty
percent (n¼ 11456) of those who entered the study between
November 1991 and February 1994 were randomly selected to take
part in a study of the epidemiology of carotid artery disease.30 Five
thousand five hundred and forty subjects accepted to participate. We
obtained full phenotypic data and successfully extracted DNA
samples from 4830 subjects (Table 4) (MDC). Blood pressure in
MDC was only studied in subjects free from antihypertensive
medication (n¼ 4001) whereas the patients on antihypertensive
medication (n¼ 829) were included when ‘hypertension’ and
‘normotension’ was studied. Two –thousand –one –hundred
seventy-one untreated subjects in MDC had previously been
investigated in the MPP.28 Clinical characteristics of all subjects
are shown in Table 4.
Phenotyping
Office blood pressure was measured twice by specially trained nurses
in the right brachial artery in the supine position after 10 min rest in
MDC and MPP using a mercury sphygmomanometer and after
15 min rest in MMHG using an ISO-STABIL 5 device (Speidel and
Keller, Jungingen, Germany). Korotkoff sounds ‘I’ and ‘V’ defined
SBP and DBP, respectively. For ABP measurements in MMHG an
ABPM 90207 device (Spacelabs Medical Inc., Redmond, WA, USA)
was used with two cuff sizes depending on arm circumference. Day-
time (one recording every 20 min) was defined as 0600–2200 and
night time (one recording every 60 min) as 2200–0600. Study
subjects were advised to relax the left arm along the body during
each measurement.
Blood pressure change over time from MPP to MDC was
expressed as percent increase in blood pressure per year that is
((blood pressure at MDCblood pressure at MPP)/follow-up time
in years)/blood pressure at MPP 100. Hypertension at MDC was
defined as being on antihypertensive treatment or having SBP or
DBP X140/90 mm Hg according to modern diagnostic criteria31
and normotension as being free from antihypertensive treatment as
well as having SBP and DBP o140/90 mm Hg. BMI was calculated
as the ratio of the weight in kilograms to the square of the height in
meters (kg/m2). Presence of diabetes mellitus was defined as having
a fasting blood glucose concentration of X6.1 mmol/l or being on
antidiabetic medication.
Genotyping
MMHG. Total genomic DNA was extracted from venous
blood by standard methods. Fourteen polymorphic microsatellite
markers, evenly distributed between 70 and 104 cM on chromosome
18, and two common SNPs localized within the NEDD4L gene
(rs4149601 and rs2288774) were genotyped. Mean marker hetero-
zygosity was 74% and mean inter-marker density 2.6 cM. Micro-
satellite markers were selected from the Marshfield map (http://
research.marshfieldclinic.org/genetics/About_Marshfield/marshfield.
htm) and genetic distances are reported accordingly. Detailed
genotyping information along with markers and polymearase chain
reaction conditions can be found at (www.endo.mas.lu.se/html/pub/
markers&manuals_MMHG.txt) (Supplementary material 1 is avail-
able for reviewer).
MDC. DNA was extracted from frozen granulocyte or buffy
coat samples using QIAamp-96 spin blood kits (QIAGEN, VWR
Sweden). One SNP (dbSNP accession number rs4149601 (G/A)) was
selected for genotyping based on functionality.18 Three additional
common SNP’s in the NEDD4L gene (rs502450 intron 1 (T/C),
rs2288774 intron 6 (C/T), rs2075403 intron 22 (A/G)) were selected
based on high population frequency18 and the fact that they belong
to separate LD blocks according to the International HapMap
project (http://www.hapmap.org/, public data release No. 14
December 2004). A detailed genotyping section can be found at
(www.endo.mas.lu.se/html/pub/NEDD4L_primers&manuals.txt)
(Supplementary material 2 is available for reviewer).
Table 4 | Blood pressure change from MPP to MDC according to rs4149601 intron 1 and rs2288774 intron 6 genotypes
and a NEDD4L risk-genotype combination
rs4149601 exon 1 G/A polymorphism (n=2093)
GG (n=898) GA (n=952) AA (n=243) AA//AG (n=1195) P-value (GG vs AA)
DSBP (mm Hg/year) 1.61 (0.73–2.73) 1.52 (0.67–2.60) 1.56 (0.59–2.51) 1.53 (0.66–2.56) 0.20
DDBP (mm Hg/year) 0.39 (0.00–1.01) 0.35 (0.00–0.95) 0.30 (0.00–0.79) 0.34 (0.00–0.91) 0.04
DSBP (%/year) 1.30 (0.59–2.32) 1.27 (0.54–2.22) 1.27 (0.47–2.17) 1.27 (0.52–2.21) 0.21
DDBP (%/year) 0.49 (0.00–1.27) 0.43 (0.00–1.21) 0.36 (0.00–1.04) 0.42 (0.00–1.16) 0.05
rs2288774 intron 6 C/T polymorphism (n=1968)
CC (n=434) CT (n=874) TT (n=660) CC/CT (n=1308) P-value (CC/CT vs TT)
DSBP (mm Hg/year) 1.60 (0.74–2.68) 1.58 (0.67–2.70) 1.51 (0.70–2.47) 1.58 (0.70–2.70) 0.22
DDBP (mm Hg/year) 0.34 (0.12–0.94) 0.38 (0.00–0.98) 0.38 (0.0–0.95) 0.37 (0.00–0.97) 0.66
DSBP (%/year) 1.33 (0.59–2.25) 1.29 (0.52–2.37) 1.25 (0.56–2.19) 1.31 (0.54–2.31) 0.34
DDBP (%/year) 0.40 (0.14–1.17) 0.46 (0.00–1.24) 0.47 (0.00–1.25) 0.44 (0.00–1.22) 0.57
rs4149601 GG + rs2288774 CC/CT (NEDD4L risk-genotype combination) vs all other subjects (n=1953)
NEDD4L risk-haplotype (n=592) Other genotype carriers (n=1361) P-value
DSBP (mm Hg/year) 1.70 (0.74–2.93) 1.53 (0.68–2.51) 0.026
DDBP (mm Hg/year) 0.42 (0.00–1.03) 0.34 (0.00–0.94) 0.047
DSBP (%/year) 1.40 (0.58–2.45) 1.25 (0.54–2.20) 0.048
DDBP (%/year) 0.52 (0.00–1.28) 0.42 (0.00–1.20) 0.063
SBP, systolic blood pressure; DBP, diastolic blood pressure; IQR, interquartile range; MPP, Malmo¨ Preventive Project; MDC, Malmo¨ Diet and Cancer.
Data are given as median IQR.
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Statistics
Quantitative trait locus variance component analysis in the MMHG
material was conducted using GENEHUNTER software version
2.0.32 Complete multipoint analysis of the statistical significance of
allele sharing identical by descent for age-, sex-, BMI-, and heart
rate-adjusted ABP phenotypes was performed between 70 and
104 cM on chromosome 18. If identity by descent allele sharing in
the sib-ships could not be directly determined, due to missing
parental genotypes, parental genotypes were estimated based on the
genotypes of their offspring using GENEHUNTER v 2.0.33 The
strength of the linkage was expressed as LOD-score (LOD) and
P-value. Allele frequencies were estimated from the MMGH
material. Allele frequencies and marker positions were incorporated
in a simulation (1000 iterations) allowing us to test the actual
P-values obtained in the linkage study using Merlin.34 A quantitative
transmission disequilibrium test35 was applied to test for association
between the two SNPs and blood pressure variation in the MMHG.
All data in MDC was analyzed with SPSS statistical software
(version 11.5, SPSS Inc. Chicago, IL, USA). Frequency differences
were analyzed by w2-test. Depending on normality, continuous
variables were tested by t-test and analysis of variance or
Mann–Whitney and Kruskal–Wallis test and presented as mean7s.d.
or as median and interquartile range. Multiple regression analysis
was used to test if genotypic effects on blood pressure were
independent of covariates. The general linear model was applied
for covariate analysis of blood pressure change over time
depending on genotype. Spearman’s test for correlations was used
to calculate correlations. Fisher’s R to Z transformation was used to
test if the correlation between fasting plasma insulin concentration
and blood pressure was dependent of genotype. All tests were
two sided and throughout Po0.05 was considered statistically
significant.
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